Nasal polyps are fleshy swellings that develop in the lining of the nose and paranasal sinuses, which are the air-filled spaces linked to the nasal cavity. They are noncancerous growths.

SAN DIEGO -- Novel ultra-long-acting biologic depemokimab reduced nasal polyps in chronic rhinosinusitis, two parallel phase III trials showed. Twice-yearly injections cut total nasal polyps score ...

SAN DIEGO -- Tezepelumab (Tezspire) reduced nasal polyps and symptoms in severe chronic rhinosinusitis while also decreasing need for further treatments, the WAYPOINT trial showed. The monoclonal ...

Tezepelumab (Tezspire) has shown significant clinical benefits in adults with severe chronic rhinosinusitis with nasal polyps (CRSwNP), including marked reductions in nasal congestion and polyp ...

Trials of Sanofi and Regeneron’s drug Dupixent (dupilumab) have shown positive results for treating patients suffering from chronic rhinosinusitis with nasal polyps, teeing up a potential new use.

Nasal endoscopic surgery for chronic sinusitis with nasal polyps results in shorter operative time, reduced intraoperative blood loss, and fewer postoperative complications compared to traditional ...

This is the first drug approved for chronic rhinosinusitis without nasal polyps. The FDA has approved fluticasone propionate nasal spray for the treatment of chronic rhinosinusitis without nasal ...

GSK said Tuesday it had started up a phase 3 study of Nucala in patients with severe nasal polyps, a chronic inflammatory disease that can cause symptoms such as facial pain, breathing problems ...

called nasal polyps. Nasal polyps can block nasal passages and lead to breathing problems, reduction in the sense of smell, nasal discharge, sleep disturbance and other adverse effects on quality ...